-
CLINICAL AND ECONOMIC EVALUATION OF ASFOTASE ALFA FOR PEDIATRIC-ONSET HYPOPHOSPHATASIA IN KAZAKHSTAN
Aug 11, 2026, 17:16 PM -
TRANSFORMING THE ASSESSMENT OF UNCERTAINTY IN HEALTH ECONOMIC MODELS USING GENERATIVE AI
Aug 11, 2026, 17:16 PM -
DIFFERENCES IN SOCIAL RISK, MENTAL HEALTH, AND CLINICAL PROFILES AMONG ADULTS WITH OBESITY TREATED WITH GLP-1 VERSUS NON-GLP-1 ANTI-OBESITY MEDICATIONS USING REAL-WORLD DATA
Aug 11, 2026, 17:16 PM -
COMPARISON OF SIMULATED TREATMENT COMPARISON AND MATCHING-ADJUSTED INDIRECT COMPARISON FOR LONGITUDINAL BINARY OUTCOMES WITH LOW POPULATION OVERLAP
Aug 11, 2026, 17:16 PM -
REAL-WORLD PERSISTENCE WITH LIRAGLUTIDE (SAXENDA) FOR WEIGHT MANAGEMENT IN ADULT PATIENTS
Aug 11, 2026, 17:16 PM -
PREDIABETES: FROM RISK TO REVERSAL—OUTCOMES AND GLYCEMIC PREDICTORS AFTER A 12-MONTH LIFESTYLE INTERVENTION
Aug 11, 2026, 17:16 PM -
CAN THE EQ-5D-5L DETECT MEANINGFUL CHANGES FOR HEALTHCARE DECISION MAKING? A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
THE CLINICAL AND HUMANISTIC IMPACT OF PEMBROLIZUMAB IN THE CZECH REPUBLIC: A POPULATION-LEVEL PAN-TUMOR MODELING STUDY
Aug 11, 2026, 17:16 PM -
PREFERENCES OF PEOPLE LIVING WITH HIV FOR INJECTABLE VERSUS ORAL ANTIRETROVIRAL THERAPY (ART): A DISCRETE CHOICE EXPERIMENT (DCE) ACROSS CHINA, US, UK, SPAIN, AND GERMANY
Aug 11, 2026, 17:16 PM -
BUDGET IMPACT OF INTRODUCING SELUMETINIB FOR SYMPTOMATIC INOPERABLE PLEXIFORM NEUROFIBROMAS IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1: A PUBLIC PAYER PERSPECTIVE
Aug 11, 2026, 17:16 PM -
REAL-WORLD CHARACTERISTICS OF MYASTHENIA GRAVIS (MG) AND GENERALIZED MG (MG-RENIRA): A SINGLE-CENTER RETROSPECTIVE STUDY IN POLAND
Aug 11, 2026, 17:16 PM -
REPLACING LONG-TERM EFFICACY EXTRAPOLATION WITH REAL-WORLD REGISTRY DATA: AROMA-INFORMED COST-EFFECTIVENESS ANALYSIS OF DUPILUMAB FOR SEVERE CHRONIC RHINOSINUSITIS WITH NASAL POLYPS IN THE UNITED KINGDOM
Aug 11, 2026, 17:16 PM -
CAN AI MATCH THE HUMAN EYE? VALIDATION OF A GENERATIVE AI TOOL FOR NEWCASTLE-OTTAWA QUALITY APPRAISAL IN SYSTEMATIC LITERATURE REVIEWS
Aug 11, 2026, 17:16 PM -
PSYCHOMETRIC EVALUATION OF THE EQ-5D-5L IN SEPSIS PATIENTS
Aug 11, 2026, 17:16 PM -
IMPACT OF REMIBRUTINIB TREATMENT ON WORKPLACE PRODUCTIVITY DUE TO CHRONIC SPONTANEOUS URTICARIA (CSU): A CANADIAN PRIVATE PAYOR PERSPECTIVE
Aug 11, 2026, 17:16 PM -
WHEN THE TAIL WAGS THE DOG II: HOW MUCH OF A MATURE OVERALL-SURVIVAL BENEFIT RESTS ON ASSUMPTION (TROPION-BREAST02)
Aug 11, 2026, 17:16 PM -
ADDRESSING AN UNMET THERAPEUTIC NEED IN GROUP 1 PULMONARY ARTERIAL HYPERTENSION (PAH): CLINICAL OUTCOMES AND ECONOMIC IMPLICATIONS OF PARENTERAL TREPROSTINIL IN THE MEXICAN SOCIAL SECURITY INSTITUTE (IMSS)
Aug 11, 2026, 17:16 PM -
EPIDEMIOLOGY AND TREATMENT ALGORITHMS OF GASTRIC CANCER IN TURKIYE: A SYSTEMATIC REVIEW
Aug 11, 2026, 17:16 PM -
INCORPORATING HEALTHCARE PROFESSIONAL OUTCOMES IN RESEARCH PROJECT FUNDING DECISIONS: USEFULNESS OF AN ADAPTED EARLY HTA INSTRUMENT
Aug 11, 2026, 17:16 PM -
3-YEAR BUDGET IMPACT OF SWITCHING PATIENTS WITH SCHIZOPHRENIA TO LONG-ACTING PALIPERIDONE (PPLAT) IN THE UAE
Aug 11, 2026, 17:16 PM
